Azitra (AZTR) Other Non-Current Liabilities (2022 - 2025)
Azitra's (AZTR) quarterly Other Non-Current Liabilities came in at $51.0 in Q3 2025, down 88.84% YoY from $457.0 in Q3 2024, and down 72.28% on a QoQ basis from $184.0 in Q2 2025.
Azitra (AZTR) Other Non-Current Liabilities (2022 - 2025) Analysis & Trends
Azitra (AZTR) has 4 years of Other Non-Current Liabilities data on file, last reported at $51.0 in Q3 2025.
- Quarterly Other Non-Current Liabilities fell 88.84% year-over-year to $51.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $51.0 (down 88.84% YoY) and the FY2024 annual result came in at $381.0, down 98.93% from the prior year.
- Other Non-Current Liabilities eased to $51.0 in Q3 2025, from $184.0 in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $158994.0 in Q2 2023 to a low of $51.0 in Q3 2025.
- A 4-year average of $30654.4 and a median of $2926.0 in 2024 frame the typical range for Other Non-Current Liabilities.
- Annual changes were most pronounced in 2023 — Other Non-Current Liabilities sank 49.56% — and 2024, when it plunged 99.25%.
- Tracing AZTR's Other Non-Current Liabilities over 4 years: stood at $70283.0 in 2022, then slumped by 49.56% to $35453.0 in 2023, then slumped by 98.93% to $381.0 in 2024, then sank by 86.61% to $51.0 in 2025.
- The last three Other Non-Current Liabilities figures came in at $51.0 (Q3 2025), $184.0 (Q2 2025), and $238.0 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Azitra | 2.53 Mn | 2.53 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 51.00 |
| Jun 30, 2025 | 184.00 |
| Mar 31, 2025 | 238.00 |
| Dec 31, 2024 | 381.00 |
| Sep 30, 2024 | 457.00 |
| Jun 30, 2024 | 2,926.00 |
| Mar 31, 2024 | 7,298.00 |
| Dec 31, 2023 | 35,453.00 |
| Sep 30, 2023 | 60,933.00 |
| Jun 30, 2023 | 158,994.00 |
| Dec 31, 2022 | 70,283.00 |